S&P 500   3,120.03 (-0.01%)
DOW   28,024.18 (+0.07%)
QQQ   202.97 (+0.03%)
CGC   14.22 (-7.24%)
BABA   184.20 (-0.70%)
GE   11.41 (-0.95%)
T   39.59 (+0.23%)
F   8.91 (-0.45%)
BAC   32.93 (+0.00%)
DIS   147.26 (+1.79%)
S&P 500   3,120.03 (-0.01%)
DOW   28,024.18 (+0.07%)
QQQ   202.97 (+0.03%)
CGC   14.22 (-7.24%)
BABA   184.20 (-0.70%)
GE   11.41 (-0.95%)
T   39.59 (+0.23%)
F   8.91 (-0.45%)
BAC   32.93 (+0.00%)
DIS   147.26 (+1.79%)
S&P 500   3,120.03 (-0.01%)
DOW   28,024.18 (+0.07%)
QQQ   202.97 (+0.03%)
CGC   14.22 (-7.24%)
BABA   184.20 (-0.70%)
GE   11.41 (-0.95%)
T   39.59 (+0.23%)
F   8.91 (-0.45%)
BAC   32.93 (+0.00%)
DIS   147.26 (+1.79%)
S&P 500   3,120.03 (-0.01%)
DOW   28,024.18 (+0.07%)
QQQ   202.97 (+0.03%)
CGC   14.22 (-7.24%)
BABA   184.20 (-0.70%)
GE   11.41 (-0.95%)
T   39.59 (+0.23%)
F   8.91 (-0.45%)
BAC   32.93 (+0.00%)
DIS   147.26 (+1.79%)
Log in

NantHealth Stock Price, Forecast & Analysis (NASDAQ:NH)

$0.91
+0.04 (+4.60 %)
(As of 11/18/2019 03:52 PM ET)
Today's Range
$0.87
Now: $0.91
$0.91
50-Day Range
$0.65
MA: $0.72
$0.87
52-Week Range
$0.45
Now: $0.91
$1.96
Volume4,918 shs
Average Volume101,313 shs
Market Capitalization$100.66 million
P/E RatioN/A
Dividend YieldN/A
Beta1.21
NantHealth, Inc, together with its subsidiaries, operates as a healthcare technology company in the United States and internationally. The company engages in converging science and technology through an integrated clinical platform to provide health information at the point of care. It develops NantHealth solutions, including molecular profiling solutions, software, and hardware systems infrastructure, which integrates patient data management, bioinformatics, and molecular medicine to enable value-based care and evidence-based clinical practice. Read More…

Industry, Sector and Symbol

Industry Data processing & preparation
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone310-883-1300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$89.46 million
Book Value($0.42) per share

Profitability

Net Income$-192,150,000.00
Net Margins-105.82%
Return on Equity-10,113.15%

Miscellaneous

Employees543
Market Cap$100.66 million
Next Earnings Date3/26/2020 (Estimated)
OptionableOptionable

Receive NH News and Ratings via Email

Sign-up to receive the latest news and ratings for NH and its competitors with MarketBeat's FREE daily newsletter.


NantHealth (NASDAQ:NH) Frequently Asked Questions

What is NantHealth's stock symbol?

NantHealth trades on the NASDAQ under the ticker symbol "NH."

How were NantHealth's earnings last quarter?

NantHealth Inc (NASDAQ:NH) issued its quarterly earnings data on Thursday, November, 7th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.07) by $0.08. The business had revenue of $22.36 million for the quarter, compared to analysts' expectations of $23.40 million. NantHealth had a negative return on equity of 10,113.15% and a negative net margin of 105.82%. View NantHealth's Earnings History.

When is NantHealth's next earnings date?

NantHealth is scheduled to release their next quarterly earnings announcement on Thursday, March 26th 2020. View Earnings Estimates for NantHealth.

What price target have analysts set for NH?

1 equities research analysts have issued 12 month target prices for NantHealth's stock. Their forecasts range from $1.00 to $1.00. On average, they expect NantHealth's share price to reach $1.00 in the next year. This suggests a possible upside of 9.9% from the stock's current price. View Analyst Price Targets for NantHealth.

What is the consensus analysts' recommendation for NantHealth?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NantHealth in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for NantHealth.

Has NantHealth been receiving favorable news coverage?

News stories about NH stock have trended very negative on Monday, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. NantHealth earned a coverage optimism score of -3.0 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the immediate future. View News Stories for NantHealth.

Are investors shorting NantHealth?

NantHealth saw a decline in short interest during the month of October. As of October 15th, there was short interest totalling 723,100 shares, a decline of 6.6% from the September 15th total of 773,900 shares. Based on an average trading volume of 97,400 shares, the short-interest ratio is presently 7.4 days. Approximately 2.2% of the company's shares are sold short. View NantHealth's Current Options Chain.

Who are some of NantHealth's key competitors?

What other stocks do shareholders of NantHealth own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NantHealth investors own include Nantkwest (NK), Trevena (TRVN), Progenics Pharmaceuticals (PGNX), Akorn (AKRX), Corbus Pharmaceuticals (CRBP), Idera Pharmaceuticals (IDRA), SCYNEXIS (SCYX), Zynerba Pharmaceuticals (ZYNE), Advaxis (ADXS) and Achaogen (AKAO).

Who are NantHealth's key executives?

NantHealth's management team includes the folowing people:
  • Dr. Patrick Soon-Shiong F.A.C.S., FRCS (C), M.D., FACS, Founder, Chairman & CEO (Age 66)
  • Mr. Ronald Allen Louks, COO & Director (Age 54)
  • Mr. Bob Petrou, Interim Chief Financial Officer (Age 47)
  • Mr. Brandon Villery, VP, Gen. Counsel & Corp. Sec.
  • Mr. Charles Hunt, VP of Marketing, Communications & User Experience

When did NantHealth IPO?

(NH) raised $91 million in an initial public offering (IPO) on Thursday, June 2nd 2016. The company issued 6,500,000 shares at a price of $12.50-$15.50 per share. Jefferies and Cowen and Company served as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers.

Who are NantHealth's major shareholders?

NantHealth's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Tower Research Capital LLC TRC (0.04%). View Institutional Ownership Trends for NantHealth.

Which institutional investors are buying NantHealth stock?

NH stock was bought by a variety of institutional investors in the last quarter, including Tower Research Capital LLC TRC . View Insider Buying and Selling for NantHealth.

How do I buy shares of NantHealth?

Shares of NH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is NantHealth's stock price today?

One share of NH stock can currently be purchased for approximately $0.91.

How big of a company is NantHealth?

NantHealth has a market capitalization of $100.66 million and generates $89.46 million in revenue each year. The company earns $-192,150,000.00 in net income (profit) each year or ($1.74) on an earnings per share basis. NantHealth employs 543 workers across the globe.View Additional Information About NantHealth.

What is NantHealth's official website?

The official website for NantHealth is http://www.nanthealth.com/.

How can I contact NantHealth?

NantHealth's mailing address is 9920 JEFFERSON BLVD, CULVER CITY CA, 90232. The company can be reached via phone at 310-883-1300 or via email at [email protected]


MarketBeat Community Rating for NantHealth (NASDAQ NH)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  249 (Vote Outperform)
Underperform Votes:  266 (Vote Underperform)
Total Votes:  515
MarketBeat's community ratings are surveys of what our community members think about NantHealth and other stocks. Vote "Outperform" if you believe NH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/18/2019 by MarketBeat.com Staff

Featured Article: Is the QQQ ETF safe?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel